Epstein Secrets

rly trajectory paralleling the U.S. East Coast, indicating an orbit tilted, or inclined, 50 to 60 degrees or more to the equator." Satellite analyst Ted Molczan "speculated the payload was either a Satellite Data System spacecraft, used to pick up and pass on signals from spy satellites in lower orbits, or

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

rly trajectory paralleling the U.S. East Coast, indicating an orbit tilted, or inclined, 50 to 60 degrees or more to the equator." Satellite analyst Ted Molczan "speculated the payload was either a Satellite Data System spacecraft, used to pick up and pass on signals from spy satellites in lower orbits, or

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

rly trajectory paralleling the U.S. East Coast, indicating an orbit tilted, or inclined, 50 to 60 degrees or more to the equator." Satellite analyst Ted Molczan "speculated the payload was either a Satellite Data System spacecraft, used to pick up and pass on signals from spy satellites in lower orbits, or

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying